ResearcherHeidelberg UniversityNo recent work listed
Pascal Probst
Matched on ORCID iD 0000-0002-0895-4015; OpenAlex author ID A5018838202. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 22
2019: 1 paper · 2020: 1 paper · 2021: 2 papers · 2022: 1 paper · 2023: 1 paper
Papers 6
- Influence of beta-blockers and other non-cancer drugs on outcomes after pancreatic cancer resection. Co-author DOI 10.1093/bjs/znac434↗
- Prognostic relevance of the revised R status definition in pancreatic cancer: meta-analysis. Last author DOI 10.1093/bjsopen/zrac010↗
- Prospective trial to evaluate the prognostic value of different nutritional assessment scores for survival in pancreatic ductal adenocarcinoma (NURIMAS Pancrea… Last author DOI 10.1002/jcsm.12796↗
- Survival Benefit of Resection Surgery for Pancreatic Ductal Adenocarcinoma with Liver Metastases: A Propensity Score-Matched SEER Database Analysis. Co-author DOI 10.3390/cancers14010057↗
- Cetuximab in Pancreatic Cancer Therapy: A Systematic Review and Meta-Analysis. Last author DOI 10.1159/000502844↗
- Meta-analysis of recurrence pattern after resection for pancreatic cancer. Co-author DOI 10.1002/bjs.11295↗
Closest collaborators
The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Thilo Hackert · 5 shared papers, 2019–2023 · strength 0.68
- Paper Influence of beta-blockers and other non-cancer drugs on outcomes after pancreatic cancer resection. DOI 10.1093/bjs/znac434↗
- Paper Survival Benefit of Resection Surgery for Pancreatic Ductal Adenocarcinoma with Liver Metastases: A Propensity Score-Ma… DOI 10.3390/cancers14010057↗
- Paper Prospective trial to evaluate the prognostic value of different nutritional assessment scores for survival in pancreati… DOI 10.1002/jcsm.12796↗
- Markus Wolfgang Büchler · 4 shared papers, 2019–2023 · strength 0.59
- Paper Influence of beta-blockers and other non-cancer drugs on outcomes after pancreatic cancer resection. DOI 10.1093/bjs/znac434↗
- Paper Prognostic relevance of the revised R status definition in pancreatic cancer: meta-analysis. DOI 10.1093/bjsopen/zrac010↗
- Paper Prospective trial to evaluate the prognostic value of different nutritional assessment scores for survival in pancreati… DOI 10.1002/jcsm.12796↗
- Markus K. Diener · 3 shared papers, 2020–2023 · strength 0.44
- Paper Influence of beta-blockers and other non-cancer drugs on outcomes after pancreatic cancer resection. DOI 10.1093/bjs/znac434↗
- Paper Prospective trial to evaluate the prognostic value of different nutritional assessment scores for survival in pancreati… DOI 10.1002/jcsm.12796↗
- Paper Cetuximab in Pancreatic Cancer Therapy: A Systematic Review and Meta-Analysis. DOI 10.1159/000502844↗
- Max Heckler · 3 shared papers, 2019–2023 · strength 0.43
- Paper Influence of beta-blockers and other non-cancer drugs on outcomes after pancreatic cancer resection. DOI 10.1093/bjs/znac434↗
- Paper Prospective trial to evaluate the prognostic value of different nutritional assessment scores for survival in pancreati… DOI 10.1002/jcsm.12796↗
- Paper Meta-analysis of recurrence pattern after resection for pancreatic cancer. DOI 10.1002/bjs.11295↗
- Felix Jakob Hüttner · 2 shared papers, 2021–2023 · strength 0.33
- Thomas P. Hank · 2 shared papers, 2021–2022 · strength 0.29
- Ulrike Heger · 2 shared papers, 2019–2021 · strength 0.23
- Ulla Klaiber · 2 shared papers, 2019–2021 · strength 0.22
- Willem Niesen · 1 shared paper, 2022 · strength 0.16
- Rosa Klotz · 1 shared paper, 2022 · strength 0.16
- Carl-Stephan Leonhardt · 1 shared paper, 2022 · strength 0.16
- Oliver Strobel · 1 shared paper, 2022 · strength 0.16
- Thomas Moritz Pausch · 1 shared paper, 2021 · strength 0.13
- Jishu Wei · 1 shared paper, 2021 · strength 0.13
- Yi Miao · 1 shared paper, 2021 · strength 0.13
- Xinchun Liu · 1 shared paper, 2021 · strength 0.13
- Henrik Nienhüser · 1 shared paper, 2021 · strength 0.12
- Tobias Förster · 1 shared paper, 2020 · strength 0.11
- Christoph Springfeld · 1 shared paper, 2020 · strength 0.11
- Matthias J. Löhr · 1 shared paper, 2020 · strength 0.11
- Masayuki Tanaka · 1 shared paper, 2019 · strength 0.10
- André L. Mihaljević · 1 shared paper, 2019 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.